FolioLanternBeta
KROSKeros Therapeutics, Inc.

Lorena Lerner

Chief Scientific Officer at Keros Therapeutics, Inc., as of Aug 20, 2026Sold $100K of stock in the past 12 months: 100% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
21%
share of stake sold at Keros Therapeutics, Inc.
28K
shares held after the latest filing, Keros Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFeb 2026: $63K to cover taxes$63KFebMarAprMayJunJulAug 2026: $37K to cover taxesAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Keros Therapeutics, Inc. (KROS)Chief Scientific OfficerAug 15, 2025Aug 20, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.